Abstract:Abstract Background: Angiogenesis is essential for the growth and metastasis of solid tumors, including breast cancer. Although the zinc finger-homeodomain transcription factor ZEB1 is implied as a key regulatory factor in multistep carcinogenesis of breast cancer, its direct role in the regulation of tumor angiogenesis has not been well elucidated. In this report, we extended our study to examine the potential effect of ZEB1 in breast cancer angiogenesis and its molecular mechanism using the in vitro and in vivo models. Materials and Methods: Quantitative RT-PCR, immunoblotting, and ELISA were used to detect ZEB1-induced expression and/or secretion of VEGF in the absence or presence of the indicated signaling pathway inhibitors (the PI3K, NF-κB, and MAPKs pathways) in MDA-MB-231 breast cancer cells. Tube formation assay was performed to detect ZEB1-driven angiogenesis using human umbilical vein endothelial cells (HUVEC). Luciferase and CHIP assays were used to determine the transcriptional activity of the wild-type and mutant VEGF promoters affected by ZEB1. A nude mouse tumor xenograft model was used to examine ZEB1-driven angiogenesis in vivo. The relationship between the expression of ZEB1 and VEGF protein in human breast cancer specimens was assessed by immunohistochemistry. Results: We found that ectopic expression of ZEB1 promotes the expression of VEGF at both the mRNA and the protein levels in MDA-MB-231 cells, which effect is specifically mediated through the p38 and PI3K pathways. The conditioned medium derived from ZEB1-overexpressing MDA-MB-231 cells significantly induces the tube formation of HUVEC compared with that from control-overexpressing cells. Importantly, elevated expression of ZEB1 resulted in an increased angiogenesis in a nude mouse tumor xenograft model. We further moved on to detect whether ZEB1 is a bona-fide transcriptional regulator of VEGF. The results of luciferase and CHIP assays showed that ZEB1 transcriptionally induces the promoter activity of human VEGF by recruiting Sp1 to its biding sites on the VEGF promoter, thus up-regulating VEGF expression in MDA-MB-231 cells. Through the study of breast cancer specimens, we found a strong positive correlation between ZEB1 and VEGF protein expression, further supporting the contribution of ZEB1/VEGF cascade to tumor angiogenesis in breast cancer. Conclusions: Our data demonstrated that ZEB1 up-regulates VEGF expression and thus induces tumor angiogenesis in breast cancer. Thus, inhibition of VEGF expression by down-regulating ZEB1 provides a potential new strategy for overcoming tumor angiogenesis. Citation Format: Qi Tong, Lingjia Liu, Lin Liang, Yang Gao, Shuang Yang. Elevated expression of ZEB1 upregulates VEGF expression and induces tumor angiogenesis in breast cancer. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 1599. doi:10.1158/1538-7445.AM2014-1599

Inactivation of Endothelial ZEB1 Impedes Tumor Progression and Sensitizes Tumors to Conventional Therapies.

Therapeutic Efficacy of ECs Foxp1 Targeting Hif1α-Hk2 Glycolysis Signal to Restrict Angiogenesis

Therapeutic Efficacy of ECs Foxp1 Targeting Hif1α-Hk2 Α-Hk2 Glycolysis Signal to Restrict Angiogenesis

ZEB1 Promotes Oxaliplatin Resistance Through the Induction of Epithelial - Mesenchymal Transition in Colon Cancer Cells

Inhibition of ZEB1 Reverses EMT and Chemoresistance in Docetaxel-Resistant Human Lung Adenocarcinoma Cell Line.

FOXF1 promotes tumor vessel normalization and prevents lung cancer progression through FZD4

Jagged1-Notch1-deployed Tumor Perivascular Niche Promotes Breast Cancer Stem Cell Phenotype Through Zeb1.

Endothelial specific YY1 deletion restricts tumor angiogenesis and tumor growth

Endothelial Zeb1 Promotes Angiogenesis-Dependent Bone Formation And Reverses Osteoporosis

Regulation of Tumor Angiogenesis by EZH2

Lentivirus-delivered ZEB-1 small interfering RNA inhibits lung adenocarcinoma cell growth in vitro and in vivo

Zeb1 Induces Immune Checkpoints to Form an Immunosuppressive Envelope Around Invading Cancer Cells.

Abstract 1599: Elevated Expression of ZEB1 Upregulates VEGF Expression and Induces Tumor Angiogenesis in Breast Cancer

Endothelial cell Notch signaling programs cancer-associated fibroblasts to promote tumor immune evasion

Decrease of Zeb1 Expression Inhibits the B16f10 Cancer Stem-Like Properties

A ZEB1/p53 Signaling Axis in Stromal Fibroblasts Promotes Mammary Epithelial Tumours

Endothelial Cords Promote Tumor Initial Growth prior to Vascular Function through a Paracrine Mechanism

Zeb1-Induced Tumourigenesis Requires Senescence Inhibition Via Activation of Dkk1/Mutant P53/Mdm2/Ctbp and Repression of Macroh2a1

Positive Reciprocal Feedback of lncRNA ZEB1-AS1 and HIF-1α Contributes to Hypoxia-Promoted Tumorigenesis and Metastasis of Pancreatic Cancer

HIF1α Counteracts TGFβ1-Driven TSP1 Expression in Endothelial Cells to Stimulate Angiogenesis in the Hypoxic Tumor Microenvironment

Tumor-Intrinsic Enhancer of Zeste Homolog 2 Controls Immune Cell Infiltration, Tumor Growth, and Lung Metastasis in a Triple-Negative Breast Cancer Model